Dr. Reddy's Laboratories Statistics

Total Valuation

Dr. Reddy's Laboratories has a market cap or net worth of INR 1.12 trillion. The enterprise value is 1.11 trillion.

Market Cap	1.12T
Enterprise Value	1.11T

Important Dates

The next estimated earnings date is Friday, January 24, 2025.

Earnings Date	Jan 24, 2025
Ex-Dividend Date	Jul 16, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.16%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	597.21M

Valuation Ratios

The trailing PE ratio is 20.97.

PE Ratio	20.97
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	5.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.33, with an EV/FCF ratio of 89.75.

EV / Earnings	20.77
EV / Sales	3.69
EV / EBITDA	13.33
EV / EBIT	16.33
EV / FCF	89.75

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.16.

Current Ratio	1.92
Quick Ratio	1.17
Debt / Equity	0.16
Debt / EBITDA	0.59
Debt / FCF	3.93
Interest Coverage	28.89

Financial Efficiency

Return on equity (ROE) is 19.27% and return on invested capital (ROIC) is 13.55%.

Return on Equity (ROE)	19.27%
Return on Assets (ROA)	10.40%
Return on Capital (ROIC)	13.55%
Revenue Per Employee	11.09M
Profits Per Employee	1.97M
Employee Count	27,048
Asset Turnover	0.74
Inventory Turnover	1.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.17% in the last 52 weeks. The beta is 0.31, so Dr. Reddy's Laboratories's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	+19.17%
50-Day Moving Average	1,268.29
200-Day Moving Average	1,275.13
Relative Strength Index (RSI)	69.75
Average Volume (20 Days)	2,564,386

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dr. Reddy's Laboratories had revenue of INR 299.87 billion and earned 53.33 billion in profits. Earnings per share was 63.95.

Revenue	299.87B
Gross Profit	177.80B
Operating Income	67.67B
Pretax Income	72.26B
Net Income	53.33B
EBITDA	81.79B
EBIT	67.67B
Earnings Per Share (EPS)	63.95

Full Income Statement

Balance Sheet

The company has 63.07 billion in cash and 48.54 billion in debt, giving a net cash position of 14.53 billion.

Cash & Cash Equivalents	63.07B
Total Debt	48.54B
Net Cash	14.53B
Net Cash Per Share	n/a
Equity (Book Value)	309.28B
Book Value Per Share	366.54
Working Capital	118.83B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 34.07 billion and capital expenditures -21.73 billion, giving a free cash flow of 12.34 billion.

Operating Cash Flow	34.07B
Capital Expenditures	-21.73B
Free Cash Flow	12.34B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 59.29%, with operating and profit margins of 22.57% and 17.79%.

Gross Margin	59.29%
Operating Margin	22.57%
Pretax Margin	24.10%
Profit Margin	17.79%
EBITDA Margin	27.28%
EBIT Margin	22.57%
FCF Margin	4.12%

Dividends & Yields

This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 0.64%.

Dividend Per Share	8.00
Dividend Yield	0.64%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	12.49%
Buyback Yield	-0.16%
Shareholder Yield	0.48%
Earnings Yield	4.76%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on October 28, 2024. It was a forward split with a ratio of 5.

Last Split Date	Oct 28, 2024
Split Type	Forward
Split Ratio	5

Scores

Dr. Reddy's Laboratories has an Altman Z-Score of 6.19.

Altman Z-Score	6.19
Piotroski F-Score	n/a